Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia X in dogs is a cosmetic issue, not a hormonal disorder, and harmful treatments should be avoided.

Acne in dark skin is influenced by environmental factors and can lead to hyperpigmentation, with various treatment options available.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Alopecia areata treatment varies, with no optimal method established yet.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Light and laser therapies show promise for treating Acne Keloidalis Nuchae, but more research is needed.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Steroid sulfatase in hair follicles may be a target for treating hair loss.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

The U.S. military's teledermatology program was effective in providing fast and successful skin care in remote locations, preventing unnecessary evacuations.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.